Salvador Borges-Neto, MD

Professor of Radiology
Professor of Medicine
Member of the Duke Cancer Institute
Campus mail Box 3949 Med Ctr, Durham, NC 27710
Phone (919) 684-7857
Email address borge001@mc.duke.edu

Expertise:

1. Diagnostic and Prognostic Utility of Cardiovascular Nuclear Medicine in  Heart Disease.
2. The Role of Cardiac PET/CT  in Cardiac Sarcoidosis and Ischemic Heart Disease.
3. The Role of Nuclear Cardiology in Diagnosis and Management of Amyloidosis.
4. Left Ventricular Dyssynchrony Evaluation by GSPECT.

I am a Professor of Radiology (Nuclear Medicine) and Internal Medicine at Duke University Medical Center. I also serve as the Medical Director of Nuclear Cardiology at Duke Health System with Duke Heart Center. I received my medical doctorate from the Federal Fluminense University in Brazil. I subsequently completed a Cardiology Fellowship at Antonio Pedro University Hospital in Brazil and a second Fellowship in the Medicine/Cardiovascular division at Brigham and Women's Hospital in Boston. I continued my education with a fellowship in Nuclear Cardiology at the Methodist Hospital Baylor College of Medicine in Houston, Texas and finally in Nuclear Medicine in the Department of Radiology at Duke University Medical Center. I have lectured extensively internationally and have published 130+ publications in peer reviewed scientific professional journals. I am a founding member of the American Society of Nuclear Cardiology, Fellow of the American College of Cardiology, Fellow of the American College of Nuclear Medicine and Fellow of the American Heart Association. My clinical and Research interests include the role of cardiac imaging in predicting outcomes and guiding therapy. I have developed one of the largest Nuclear Cardiology Data Bases in the US. More recently my primarily research interest also includes the use of New Radiopharmaceuticals for the Diagnosis and Treatment of Oncologic Diseases (Theranostics). I have led a Team for the implementation of Diagnosis and Treatment of Neuroendocrine Tumors which became a Center of Reference for this Disease Diagnosis and Treatment with PRRT. serving as the PI for Expanded Access for Therapeutic Use of 177-Lu-DOTAO-Tyr3-Octreotide (Advanced Accelerator Applications SA – AAA) –Compationate Use – “177 Lu-Dotatate for Midgut Neuroendocrine Tumors and 177 Lu-Dotatate for GPENET’. Clinical Trials.Gov. 

Education and Training

  • Nuclear Medicine Residency, Duke University School of Medicine, 1992 - 1993
  • Research Fellowship, Duke University School of Medicine, 1991 - 1991
  • Research Fellowship, Baylor College of Medicine, 1986 - 1986
  • Research Fellowship, Harvard University , 1984 - 1985
  • Clinical Fellowship, Federal University of Fluminense (Brazil), 1982 - 1984
  • Intern in Medicine, Federal University of Fluminense (Brazil), 1981 - 1982
  • M.D., Federal University of Fluminense (Brazil), 1981

Publications

Fudim, Marat, and Salvador Borges-Neto. “Utility of diastolic dyssynchrony in the setting of cardiac resynchronization therapy.” J Nucl Cardiol 28, no. 6 (December 2021): 2644–46. https://doi.org/10.1007/s12350-019-01889-4.

PMID
31512196
Full Text

Fudim, Marat, Mouhammad Fathallah, Linda K. Shaw, Olga James, Zainab Samad, Jonathan P. Piccini, Paul L. Hess, and Salvador Borges-Neto. “The prognostic value of diastolic and systolic mechanical left ventricular dyssynchrony among patients with coronary artery disease and heart failure.” J Nucl Cardiol 27, no. 5 (October 2020): 1622–32. https://doi.org/10.1007/s12350-019-01843-4.

PMID
31392509
Full Text

Thorpe, Matthew P., Ari Kane, Jason Zhu, Michael A. Morse, Terence Wong, and Salvador Borges-Neto. “Long-Term Outcomes of 125 Patients With Metastatic Pheochromocytoma or Paraganglioma Treated With 131-I MIBG.” In J Clin Endocrinol Metab, Vol. 105, 2020. https://doi.org/10.1210/clinem/dgz074.

PMID
31614368
Full Text

Baldeosingh, Sacha C., Michael W. Taylor-Cho, Linda G. Romano, John R. Knight Ii, and Salvador Borges-Neto Senior. “Optimal efficient imaging time for identification of sentinel lymph node with Tc-99m Tilmanocept in breast cancer patients.” In Am J Nucl Med Mol Imaging, 10:243–48, 2020.

PMID
33224620
Scholars@Duke

Fudim, Marat, Mouhammad Fathallah, Linda K. Shaw, Peter R. Liu, Olga James, Zainab Samad, Jonathan P. Piccini, Paul L. Hess, and Salvador Borges-Neto. “The Prognostic Value of Diastolic and Systolic Mechanical Left Ventricular Dyssynchrony Among Patients With Coronary Heart Disease.” In Jacc Cardiovasc Imaging, 12:1215–26, 2019. https://doi.org/10.1016/j.jcmg.2018.05.018.

PMID
30031704
Full Text

Pages